2013-08-30 Adrenergic Drugs Flashcards

1
Q

Objective 1: For catecholamines, describe their:

  • -synthesis
  • -storage
  • -release
  • -removal
  • -interactions w/ drugs
A

Catecholamine

terminal NE stores replenished via:

a) reuptake
b) de novo synthesis

  • -de novo synthesis:
    1. tyrosine actively transported in
    2. — tyr hydroxylase —> DOPA —> decarboxylase —> dopamine

–storage: the dopamine synth’d in cytosol is then stored in vesicles where it is…

–synth: …made into NE via dopamine β-hydroxylase in the vesicle

–storage: stored in vesicle until AP arrives

–release: AP —> Ca2+ influx —> triggers fusion of vesicle w/ PM = exocytosis of NE

–removal: diffusion, reuptake, metabolization (via MAO and COMT, catechol-o-amine methyl transferase which are both high in liver —> S and glucuronate conjugates —> urine)

–interactions w/ drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pharm card: Epinephrine

A

SEE ALSO LANG CARD 2.03

Drug class: pharmacologic class—direct-acting, non-selective adrenergic agonist; therapeutic class—vasopressor, cardiac stimulant, bronchodilator, adjunct to local anesthetics, treatment for anaphylaxis

Pharmacodynamics: major action is to stimulate peripheral alpha-1 adrenoceptors, thereby leading to vasoconstriction (resistance arterioles, increase SVR) and venoconstriction (in capacitance vessels, increase preload); beta-1 receptors leading to tachycardia and increased contractility; and beta-2 receptors leading to bronchodilation; these actions are also helpful in severe allergic reactions (e.g. anaphylaxis) by stabilizing mast cells

Pharmacokinetics: can be given iv (immediate), IM (variable), SC 5-15 min), and via inhalation (1-5 min onset), ophthalmic topical; metabolized by COMT and then renally excreted;

Toxicity: excessive vasoconstriction, HTN, hemorrhagic stroke, angina, arrhythmias,
Interactions: risk of excessive hypertension in patients taking propranolol

Special considerations: utility with local anesthetics; drug of choice in severe anaphylactic reactions (along with others)

Indications and dose/route: for anaphylaxis, 0.1-0.5 mg SC or IM; for cardiac arrest, 1-5 mg IV push; for infusion, 1-4 mcg/min; also for allergy-induced asthma

Monitor: BP, HR, rhythm, infusion site, evidence of extravasation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pharm card: Norepinephrine

A

NO LANG CARD

Drug class: pharmacologic class—direct-acting, non-selective adrenergic agonist; therapeutic class—vasopressor, vasoconstrictor

Pharmacodynamics: major action is to stimulate peripheral alpha-1 adrenoceptors, thereby leading to vasoconstriction (resistance arterioles, increase SVR) and venoconstriction (in capacitance vessels, increase preload). This increases CO, SVR, and MAP, but decreases blood flow to vulnerable tissues like skin, muscle, and kidney. Also, stimulates beta-1 receptors in the heart, increasing HR and contractility. Main effects are vasoconstriction and cardiac stimulation.

Pharmacokinetics: F ~100%. Given IV only. Metabolized by COMT and MAO, mostly in liver. Metabolites are excreted in urine. Half-life 1-2 minutes (e.g. can be titrated quickly IV). Can cross the placenta, but not the blood/brain barrier.

Toxicity: excessive vasoconstriction in mesenteric vessels, peripheral arterioles causing ischemia, infarction, gangrene; reflex bradycardia

Interactions: use cautiously in patients taking an MAO inhibitor such as phenelzine (use lower doses); risk of excessive hypertension in patients taking propranolol

Special considerations: correct volume depletion with IV fluids BEFORE giving NE infusion; select infusion site carefully—extravasation is a major problem; monitor patient and BP continuously in ICU setting; use cautiously in pediatric and geriatric patients

Indications and dose/route: for adults with acute hypotension and shock (related to low SVR) infuse 2-12 mcg/min

Monitor: BP, HR, infusion site, evidence of extravasation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pharm card: dopamine

A

NO LANG CARD

endogenous, non-selective catecholamine

  • -actiavtes β1-AR in heart
  • -tx: shock, acute HF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pharm card: isoproterenol

A

extremely potent β-AR (non-selective for β-ARs)

  • -potent vasodilator
  • -poz chronotropy
  • -adverse: tachy, BP, arrythmias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pharm card: phenylepherine (neosynephrine, Sudafed PE)

A

See LANG card

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pharm card: clonidine (Catapress)

A

NO LANG CARD

MOA: α2-AR agonist; epidurally prevents pain signal transmission to the brain, producing analgesia at spinal presynaptic and postjunctional α2-adrenergic receptors

indications: HTN, menopausal flushing, migraine (severe cancer-related pain, ADHD in kids, Tourettes syndrome in kids)

  • -po: prolonged hypotensive response
  • -i.v: acute hypertensive response followed by hypotension
  • -dermal patch - ?

adverse effects: dry mouth, sedation, contact dermatitis

precautions: rebound HTN w/ abrupt d/c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pharm card: dobutamine

A

see LANG card

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharm card: albuterol

A

β2-AR agonist

bronchodilator: oral, inhalation or IV
adverse: tachy, tremor, tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pharm card: Ephedrine

A

No LANG Card (similar to amfetamine lang card)

  • -indirect-acting agonist
  • -alkaloid obtained from plant
  • -increase NE release —> direct agonism
  • -prolonged action duration, potent CNS stimulant

Uses: nasal decongestant (psuedoephedrine), tx of hypotension

Adverse: HTN, insomnia, tachyphylaxis (an acute (sudden) decrease in the response to a drug after its administration.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pharm card: Amphetamine

A

See LANG card

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pharm card: Tyramine

A

Not a drug. No Lang card.

Indirect acting adrenergic agonist

  • -causes release of catecholamines from storage
  • -high conc in fermented foods; made from fermentation of Tyrosine
  • -metabolized by liver MAO
  • -caution to pts on MAOIs—> severe HTN

Per wiki: “Foods containing considerable amounts of tyramine include meats that are potentially spoiled or pickled, aged, smoked, fermented, or marinated (some fish, poultry, and beef); most pork (except cured ham); chocolate; alcoholic beverages; and fermented foods, such as most cheeses (except ricotta, cottage, cream and Neufchâtel cheeses), sour cream, yogurt, shrimp paste, soy sauce, soybean condiments, teriyaki sauce, tofu, tempeh, miso soup, sauerkraut, broad (fava) beans, green bean pods, Italian flat (Romano) beans, snow peas, avocados, bananas, pineapple, eggplants, figs, red plums, raspberries, peanuts, Brazil nuts, coconuts, processed meat, yeast, and an array of cacti.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pharm card: cocaine

A

See Lang card

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Clicker Q: What are s/sx in EtOH/TCA interaction?

What is best pharm mgmt?
A. timolol
B. metoprolol
C. prazosin
D. phentolamine
E. isoproterenol
A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
Which drug is absolutely contraindicated in EtOH/TCA interaction?
A. phenozybenzamine
B. metoprolol
C. prazosin
D. phentolamine
E. labetolol
A

B - metoprolol is contraindicated; it will lower HR, but all the epi that can’t bind β ARs will be freed up and bind to α ARs further increasing HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the different subclasses of sympathomimetics? Give an example drug for each.

A
Direct (e.g. epi, NE)
Indirect:
--affecting release (e.g. amphetamines)
--affecting reuptake (e.g. cocaine)
--affecting degradation (e.g. tranylcypromine)
17
Q

NE vs. epi

A

epi has been demethylated (= more hydrophobic?)

18
Q
Big picture activation of:
α1-AR f(x)
α2-AR f(x)
β1-AR f(x)
β2-AR f(x)
A
α1-AR = contaction and constriction
(α2-AR = inhibits NE release)
β1-AR = incr chronotropy and ionotropy
β2-AR = relaxes airway and uterine SMM
19
Q

References for this lecture:

A

Katzung Chapters 9 & 10

20
Q

What are the three mechanisms of sympatholysis?

A

A. Decrease sympathetic outflow from brain
B. Supress nerve terminal NE
—-inhibit synth
—-deplete granules
—-supress release
C. Block postsynaptic receptors (“cleanest” way)

21
Q

Compare/contrast reversible vs. irreversible adrenergic blockade. Give one example of each.

A

Irreversible (e.g. phenoxybenzamine)

  • -doesn’t dissociate
  • -antagonism outlasts presence of compound
  • -block is insurmountable, can’t overcome it by giving more NE

Reversible (e.g. phentolamine or prazosin)

  • -antagonist dissociates from receptor
  • -produce equilibrium blockade
  • -block disappears as the drug is metabolized
22
Q

structure of adrenergic antagonists

A

unlike most of the adrenergic agonists, the antagonists often look nothing like the chemical compounds they inhibit (i.e. catecholamines)

23
Q

Big Picture non-selective α-AR-blockers (both reversible and irreversible)

A

vasodilation, lower BP

Reversible - more rarely used (e.g. phentolamine)
Irreversible - use in peripheral vasospasm (e.g. dibenzyline)

Adverse: hypotension, tachy

24
Q

Big Picture selective α2-blockers

A

not used clinically

25
Q

Big Picture selective α1-blockers

A

vasodilate —> reduce art pressure

  • -no reflex tachy
  • -useful for HTN and BPH (relaxes bladder sphincter tone; inhibits hypertrophy of bladder and prostate)

no decr in cardiac function

(e.g. prazosin)

26
Q

phenoxybenzamine

A

See LANG card

27
Q

Beta blocker complications in diabetics? Why?

A

Beta2 blockade decreases glycogenolysis and gluconeogenesis; also suppresses the s/sx of hypoglycemia

28
Q

Effect of β1 on RAAS?

A

Blockade of β1 on JGA inhibits renin release

29
Q

β-AR blockers: big picture

A

“selectivity” is a relative term
–propranolol is non-selective

Tx: HTN, arrythmias, IHD (also hyperthyroid, glaucoma, migraine, anxiety)

Well-absorbed p.o. (Cmax at 1-3 hrs) but have extensive first-pass metab (t1/2 ~3-10hrs)

DO NOT d/c abruptly, taper down

drug interactions: e.g. verapamil

caution w/: airway dz, diabetes, HF

structures: huge and heterogeneous in shape

30
Q

propranolol (inderal)

MOA
Txs
Adverse
Other

A

[See RANG 5.04]

MOA: non-selective β-AR blocker (equal affinity for β1 and β2)

Tx: HTN, IHD, life threatening arrythmias (IV)

Adverse: severe brady, CHF, bronchoconstriction, hypoglycemia, aggravated PVD

Other: membrane stabilizing effect observed at higher concentrations (anesthetic, blocks all APs per wiki)

  • -degree of antagonism depends on pre-existing level of symp tone
  • -highly lipophilic so readily enters CNS
31
Q

Timolol

A

No LANG card

MOA: non-selective β-AR blocker

Tx: open-angle glaucoma (eye drops)

Adverse: bronchoconstriction (if inhaled??)

Other: no intrinsic sympathomimetic activity (ISA)

  • -no membrane stabilization
  • -low lipophilicity
32
Q

Pindolol

A

MOA: non-selective β-AR blocker w/ ISA (doesn’t block it down to zero, useful in pts susceptible to brady)
–useful in pts dependent on symp drive b/c of poor cardiac reserve

Tx: angina, HTN

Adverse: bradycardia, bronchoconstriction

Big thing: has intrinsic sympathomimetic activity

  • -also partial agonist activity (?!) what the fuck is the drug?
  • -low degree of membrane stabilization
33
Q

Sotalol

A

MOA: non-selective β-AR blocker; also K+ channel blocker
—Prolongs cardiac AP

Tx: atrial and ventricular tacharrhythmias

34
Q

Metoprolol (Lopressor)

A
β1 selective AR blocker
no ISA
hepatic biotrans (okay in pts w/ kidney dz)

Tx. HTN and IHD

Adverse: bradycardia, bronchoconstriction

35
Q

atenolol (tenormin)

A

[Rang 2.02]

β1 selective AR blocker

Tx: HTN and IHD

Adverse: renal clearance so watch out for kidney DZ!; bradycardia, bronchoconstriction

36
Q

labetolol

A

MOA: β-AR non-selective blocker AND α1-blocker
—- β1 = β2 >/= α1 > α2

Tx: HTN, pheochromocytoma

Adverse: bradycardia, bronchoconstriction

37
Q

Carvedilol (Coreg)

A

.MOA: β-AR non-selective blocker AND α1-blocker
—- β1 = β2 >/= α1 > α2

antioxidant effects
improves survival w/ HF